Suzuki, S., Toyoma, S., Kawasaki, Y., Koizumi, K., Iikawa, N., Shiina, K., . . . Yamada, T. (2021, October). Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Medicina.
Chicago Style (17th ed.) CitationSuzuki, Shinsuke, et al. "Clinical Outcomes of Cetuximab and Paclitaxel After Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma." Medicina Oct. 2021.
MLA (9th ed.) CitationSuzuki, Shinsuke, et al. "Clinical Outcomes of Cetuximab and Paclitaxel After Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma." Medicina, Oct. 2021.
Warning: These citations may not always be 100% accurate.